During the past decade, Klinikum Remscheid GmbH conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Klinikum Remscheid GmbH" are "Leukemia" (2 trials), "Acute Myocardial Infarction" (1 trials), "Heart Failure" (1 trials) and "Lymphoma" (1 trials). Many other conditions were trialed in "Klinikum Remscheid GmbH" in a lesser frequency.

Most popular intervention types in "Klinikum Remscheid GmbH" are "Drug" (5 trials), "Biological" (3 trials), "Other" (3 trials), "Procedure" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "allogeneic bone marrow transplantation" (2 trials), "cyclophosphamide" (2 trials), "cytarabine" (2 trials), "hydroxyurea" (2 trials) and "peripheral blood stem cell transplantation" (2 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Remscheid GmbH" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Klinikum Remscheid GmbH". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Klinikum Remscheid GmbH, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Remscheid GmbH, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".